The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks Doc83. It could be that it was suspended for that time after Numis acquisition and now it's been rubber stamped as active by DB. Would be good to see if you get a response. 8p forecast, 2p higher than SP, signals some belief that they don't see the company running out of money suddenly or hitting a wall?
Fruits - it has definitely been lodged under Paul Cuddon's name, so while it is under the DB umbrella, it is surely and simply to do with Cuddon's own stocks that he covers, rather than DB as a house having decided to start covering it.
Could of course be wrong. I'll see if I can get in touch with him to confirm if there is a new note on SNG from him.
Doc83, Deutsch Bank bank concluded Numis takeover 7 months ago. This coverage is new, so I’d assume DB initiated.
Highly pathogenic avian influenza H5N1 is certainly starting to look inevitable to have human to human transmission and be the next pandemic. I'm sure many of you follow the same scientists as me like your Brights, Farrar etc and we are seeing very early warning signs.
SNG should be ahead of the game here and be prepping plans in advance ready to fast pivot to H5N1 instead of SARS-COV-2. There is much science showing efficacy of interferon in relation to H5N1 in preventing disease. I think a good question for SNG would be what plans do you already have ready for a H5N1 pivot?
SNG may well get to ride the coat tails of another pandemic but hopefully this time its partnered with a bigger pharma.
Vaccine manufacturers currently working on vaccines for H5N1 and testing companies looking for permission to start creating tests in USA signs are ominous.
MrCosts.
Explained by Doc83 below. No real substance to it.
There is no 10% drop either. One small sell, amidst a number of small buys at around the current share price.
The next substantial RNS should be instructive? I have thought the same in the past, so I shall continue to wait, and see what eventually happens?
BARDA promised Synairgen they would look for another suitable route forward when the ACTIV2 programme was shelved. (according to Synairgen anyway) Then STRIVE launched - which was about as suitable as anyone could have imagined, particularly given it's ambitions to trial drugs against a range of viruses - and SNG was overlooked. STRIVE now has 2 protease inhibitors ( last time I looked ) grinding through to a conclusion. If there was an easy fit for SNG in the states this was it.
Against this is the fact that we know one of the P2 trials will be in the US, which is supported by the the reported remark from Simon Shaw in relation to the P2 programme, saying that approvals were progressing better in the US than in the UK. And the fact that the company's website is still clearly aimed at the US.
My feeling remains that Synairgen is still on its own - in terms of major national and international support - possibly with support from J&J and/or AZ. I don't think a major platform trial is likely - either in relation to Fruits's 100 days or anything Barda might be launching. The one intriguing counter point to this, remains the Porton Down IV studies, which does seem to point to something significant - although in truth bevause of the company's silence on the matter it may still turn out that Synairgen initiated the tests
Ah, stand down. It's Paul Cuddon who was at Numis, who have been bought out by DB with Paul Cuddon being ported across. So it's not really new coverage.
TP - what's the good reason for the introduction?
I will take 8p/Hold from DB rather than Ghia’s recent assessment. There is no update to underpin it, although I agree that there is probably a good reason for its introduction.
I shan’t mention trolls on this forum again, but will continue to filter their messages as before. I now believe that most contributors’ assessment of Sakura7 is correct. S/he initiated the most ludicrous conversation I have seen on a share discussion board.
I hope that today’s DB rating, will soon be followed by a significant update from Synairgen to upwardly reset the company’s ludicrous valuation, currently based on our cash reserve?
GLALTIs.
10% drop on the 'news'.
Probably best if we don't get any updates
"Deutsche Bank initiates Synairgen with 'hold' - target 8 pence"
That is unusual IMO. Why a large IB would cover Synairgen anyway, and especially when there's been zero news for so long...
...Unless they do expect something...
Yes this is the news, now showing here...!
Deutsche Bank initiates Synairgen with 'hold' - target 8 pence
Must have been prompted by something going on?
Holder for a few years, been stung like many others on the P3. I have an expensive hobby investing in crap British biotechs.
NrN
“RnR for SNG Promotions present the first day of their Caribbean open-air fete”.
You mean this FB post? :-)
Another site is showing a NRN today for SNG, I have
searched but cannot find anything??
Every link or 'update' either contains the words 'anticipated to start...' or 'subject to...'
We are not even linked to the article and the plan is to start BARDA next gen later this year.
No update from the company to tells us BARDA have spoken to us.
It's just guess work from Tommy.
Yes, smiling at 6p. Fantastic.
Positive posts clearly wind you and your group up.
That only makes me smile and post more.
Thank you Tommy, a genuine shareholder with clear intent for good news.
Https://medicalcountermeasures.gov/newsroom/2024/ban/
BARDA has unveiled the first two hubs of the next generation of the BARDA Accelerator Network (BAN): the Diagnostics and Medical Devices Hub and the Therapeutics and Vaccines Hub. Three additional hubs are anticipated to be announced later this year.
Together, the five hubs will serve as a global network to foster the growth of the health security innovation ecosystem with commercialization and wraparound support to enable development, evaluation, validation, and commercialization of next-generation medical countermeasures (MCMs). These MCMs include therapeutics, vaccines, diagnostics, medical devices, digital health tools, and enabling technologies focused on public health preparedness and response.
Ghia is a wind up merchant, just here for attention IMHO !!
Roll on the results RNS so we have some facts to discuss !
GLA!
That’s quite a change from your last post proclaiming finances isn’t a problem we just need to see the plan Ghia?
Your previous view would seems to have ruled out option 3 or have you changed your view?
Not sure why you haven't include the scenario where they can't make any announcements due to commercial sensitivity. They will, as most will agree, be the minor partner in any such scenari,o and won't therefore be at liberty to dictate any comms output. That will be a consensus matter. That will be dictated by bigger player/s. I think this is an option as worthy of consideration as others imho.
So the hires of CFO, CMO, FC and some clinical trial peeps before Christmas was for what exactly? Fun? Please explain the logic.
I find it concerning that the narrative here is so
Blinkered, strong parallels with the closing days of many AIM stock of the past.
Just to be clear there are 3options not the 2options that Tommy is so keen to present.
1 - They have info and are deliberately witholding (Fanciful)
2 - They are not ready to divulge as they don’t have all the info yet ( this is the optimists view fingers crossed)
3 - They have nothing to say because sadly things are not progressing as they had hoped (a distinct possibility that cannot be ignored)
XEL had proven reserves of North Sea oil and a technique to extract they never made it. Yet in the final days it was their job not to admit this and to remain positive.
We have a drug that we are pretty confident works and a delivery method… It’s the boards job to attempt to commercialise it right until the end.